Stephanie Quick, LCSW Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 405 Brooklyn St, Superior, MT 59872 Phone: 406-532-9150 |
April Ann Quinlan, LCPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1203 5th Ave. East, Superior, MT 59872 Phone: 068-808-8054 |
Jenny Lynn Miller, LAC-BBH-LAC-LIC-4969 Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 304 4th Ave E, Superior, MT 59872 Phone: 406-822-5422 |
Leann Joyce Anderson, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 304 4th Ave E, Superior, MT 59872 Phone: 406-822-5422 Fax: 406-822-0786 |
Stewart Andrew Mccracken, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 491 Shaw Gulch Ln, Superior, MT 59872 Phone: 406-304-6371 Fax: 866-261-3089 |
Carissa Kuhl, LCPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 102 River Street, Superior, MT 59872 Phone: 406-200-8282 |
Ms. Nancy M Smith, MSW, LCSW, LAC Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 110 2nd Ave. E., Suite 1, Superior, MT 59872 Phone: 406-822-5422 Fax: 406-822-5423 |
News Archive
Thickness of the cornea, the thin, transparent layer covering the eye, may be an important factor in considering treatment options for patients with glaucoma, according to an article appearing in the September issue of The Archives of Ophthalmology, one of the JAMA/Archives journals.
Now that the federal government's vaccine court has again denied claims that mercury in vaccines cause autism, frankly, we have to agree with them. Because mercury poisoning and autism produce identical symptoms, we parents of autistic children in America have been barking up the wrong tree. Mercury in vaccines causes mercury poisoning which causes brain damage which can look like autism.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany announces today that it will be presenting new data from several studies of Erbitux (cetuximab) in a range of solid tumor types including the first Phase II data in breast and prostate cancers. These data will be presented at the forthcoming 35th European Society for Medical Oncology Congress (ESMO) in Milan, October 8-12, 2010.
With a disproportionate number of black cisgender women in the U.S. becoming HIV positive, researchers at The University of Texas Health Science Center at Houston are sharing critical health information through an atypical venue: the emergency room.
Eleven Biotherapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today reported financial results and operational highlights for the quarter ended March 31, 2014.
› Verified 8 days ago